Neweigy, H., Gouida, M., Salem, M., El Naggar, M. (2022). Toxicological and pathophysiological alterations accompanied treating cancer with the Egyptian cobra (Naja haje) crude venom on mice. International Journal of Cancer and Biomedical Research, 6(1), 19-29. doi: 10.21608/jcbr.2022.77445.1215
Hosni Neweigy; Mona samy Gouida; Mohamed Labib Salem; Mohamed Salah El Naggar. "Toxicological and pathophysiological alterations accompanied treating cancer with the Egyptian cobra (Naja haje) crude venom on mice". International Journal of Cancer and Biomedical Research, 6, 1, 2022, 19-29. doi: 10.21608/jcbr.2022.77445.1215
Neweigy, H., Gouida, M., Salem, M., El Naggar, M. (2022). 'Toxicological and pathophysiological alterations accompanied treating cancer with the Egyptian cobra (Naja haje) crude venom on mice', International Journal of Cancer and Biomedical Research, 6(1), pp. 19-29. doi: 10.21608/jcbr.2022.77445.1215
Neweigy, H., Gouida, M., Salem, M., El Naggar, M. Toxicological and pathophysiological alterations accompanied treating cancer with the Egyptian cobra (Naja haje) crude venom on mice. International Journal of Cancer and Biomedical Research, 2022; 6(1): 19-29. doi: 10.21608/jcbr.2022.77445.1215
Toxicological and pathophysiological alterations accompanied treating cancer with the Egyptian cobra (Naja haje) crude venom on mice
3Zoology Department, Faculty of Science, Tanta University, Tanta, Egypt
4Zoology Department; Faculty of Science; Suez Canal University
Abstract
Cancer is one of the human mortality leading causes. While there are many tumor treatment modalities, but chemotherapy remains the most effective treatment, although its severe side effects and developed resistance. That huge challenge forces pharmaceutical industries to investigate novel antitumor strategies, especially from natural resources. The present work aimed to study the biochemical and histological alterations after Naja haje crude venom treatment to detect its antitumor efficacy. After experimental determination of Cobra venom LD50, mice were divided into three main groups, control, solid tumor and soft tumor. Control sub-groups contain saline-treated group, positive control treated with standard drug (Cisplatin), and 3 groups treated with cobra venom (1/10, 1/20 LD50 and 1/30 LD50). Solid tumor sub-groups contain saline-treated group, Cisplatin-treated group and 2 groups treated with cobra venom (1/10 and 1/20 LD50). Soft tumor sub-groups contain saline-treated group, Cisplatin-treated group and 3 groups treated with cobra venom (1/10, 1/20 LD50 and 1/30 LD50). Serum, liver, kidney, heart, spleen, and solid tumor tissues were collected for biochemical and histopathological investigations. The histological and biochemical results confirmed the significant cellular injury in liver. Kidney, heart and spleen, and its severity decreased by decreasing venom dose. Also, the direct anti-tumor effects of Cobra venom in both solid and soft tumors were significantly confirmed in comparing with cisplatin groups. Significant cytotoxic activities upon tumor cells rather than normal cells suggest a clinical potentiality for Naja haje crud venom. Further investigation should be conducted to confirm its safety and efficacy as an antitumor therapeutic agent
Top